A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

This study has been completed.

Sponsor:

Jazz Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT01643408

First Posted: July 18, 2012

Last Update Posted: May 9, 2014

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.